This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
11/13/2025
Good morning, all, and thank you for joining us on today's BioCeres Crop Solutions Fiscal First Quarter 2026 Financial and Operational Results. My name is Drew, and I'll be the operator on the call today. After the prepared remarks, we will have a Q&A session. If you would like to register for a question today, please press star followed by one on your telephone keypad. And to withdraw your question, it's star followed by two. With that, it's my pleasure to hand over to Paola Savanti, Head of Investor Relations to begin. Please go ahead when you're ready.
Thank you. Good morning and welcome everybody to Biosphere Scrap Solutions fiscal first quarter 2026 earnings conference call. Our prepared remarks today will be led by our chief executive officer, Federico Trucco, myself as head of investor relations. Both of us as well as will be available for the Q&A session afterwards. We're also joined in today's call by our general counsel, Jose Roque. During this call, we will make forward-looking statements. These statements are based on current expectations and assumptions that are subject to various risks and uncertainties. I refer you to the forward-looking statements section of the earnings release and presentation, as well as the recent filings with the SEC. We assume no obligation to update or revise any forward-looking statements to reflect new or changed circumstances. In today's presentation, we will be making references to certain non-GAAP financial measures. Reconciliations of the non-GAAP measures can be found in our earnings press release. This conference call is being webcast and the link is available at our investor relations website. It is now my pleasure to turn the call over to Federico.
Thanks, Paula, and good morning to everyone. Thank you for joining us today. Please turn to slide number three for an overview of the highlights of our first fiscal quarter. Despite the drop in revenues in the quarter compared to the year-ago numbers, gross profit remained almost equal at $36 million with a gross margin expansion of 650 basic points. This shows how the seed business model transition as well as a lower emphasis on opportunistic third-party product sales are resulting in a similar aggregated gross profit at a much lower working capital expense. In fact, we have seen a sequential improvement on working capital despite the first quarter's seasonally high needs, as we'll discuss in a minute. On the cost front, we continue to see the results of our cost reduction initiatives as well as business model transition. With both variable and fixed SG&A declining significantly, resulting in meaningful improvements in operating profits and adjusted EBITDA. Please turn to the next slide. This quarter reflects clear progress on the priorities we set for the year. Improve the quality of our revenues, protect margins, and operate with discipline. While we continue to pursue our core purpose, which is to enable a better, still highly productive agriculture. This slide shows the three main KPIs that we'll track throughout the year. In our last call, we committed to operating above the 40% gross margin level, getting closer to four months of working capital in terms of annual sales, and targeting profitability above 20% of adjusted EBITDA over sales, for which we needed not only to expand margins, as we are doing, but also to reduce costs, targeting a $10 to $12 million reduction in annual SG&A. As you can see in the numbers here, we have operated well above the gross margin limit we established for ourselves, doubled our percent adjusted EBITDA compared to that of fiscal year 25, and already got to the same level, 17%, that we achieved in fiscal 24. We have done this while remaining close to our working capital target of four months in a seasonally demanding quarter. One important highlight is our SG&A improvement. Both variable and fixed SG&A have improved significantly, achieving 50% of our top-of-the-range expected annualized savings in just one quarter. I will now pass on the call to Paula for a more in-depth analysis of these and other aspects of our financial performance. Paula?
You're reading a preview of the BIOX Q1 2026 earnings call.
Free account.
